Peter C. Brandt's Net Worth
$4.46 Million
Who is Peter C. Brandt?
Peter C. Brandt has an estimated net worth of $4.46 Million. This is based on reported shares across multiple companies, which include IN8BIO, INC., REXAHN PHARMACEUTICALS, INC., AUXILIUM PHARMACEUTICALS INC, EPOCRATES INC, and NOVEN PHARMACEUTICALS INC.
SEC CIK
Peter C. Brandt's CIK is 0001434099
Past Insider Trading and Trends
2011 was Peter C. Brandt's most active year for acquiring shares with 33 total transactions. Peter C. Brandt's most active month to acquire stocks was the month of August. 2015 was Peter C. Brandt's most active year for disposing of shares, totalling 7 transactions. Peter C. Brandt's most active month to dispose stocks was the month of December. 2011 saw Peter C. Brandt paying a total of $672,525.15 for 412,035 shares, this is the most they've acquired in one year. In 2009 Peter C. Brandt cashed out on 857,712 shares for a total of $4,867,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IN8BIO, INC. (INAB) Snapshot price: $1.2298
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +44.92% | 81.97K |
—
|
—
| 264.44K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +136.33% | 105.26K |
$1.90 | $199,999.70 | 182.47K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $2.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +500.00% | 125K |
$1.17 | $146,855.13 | 150K |
Sep 8 - Sep 9
| |||
Form 4
|
∞
| 25K |
$0.96 | $24,122.50 | 25K |
Sep 6 - Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.00K |
$36.53 | -$182,650.00 |
0
|
Jan 29
| |||
Form 4
| +25.00% | 5K |
—
|
—
| 25K |
May 21
| |||
Form 4
| +33.33% | 5K |
—
|
—
| 20K |
May 1
| |||
Form 4
| +50.00% | 5K |
—
|
—
| 15K |
Jun 21
| |||
Form 4
|
∞
| 10K |
$20.10 | $200,998.20 | 10K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPOCRATES INC No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.73K |
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
| +82.38% | 20.59K |
—
|
—
| 45.59K |
Dec 7
| |||
Form 4
| +139.65% | 14.57K |
$9.78 | $142,431.34 | 25K |
Sep 7
| |||
Form 4
|
∞
| 10.43K |
$9.58 | $99,971.98 | 10.43K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVEN PHARMACEUTICALS INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -183.33K |
$16.50 | -$3,024,994.50 |
0
|
Aug 27
| |||
Form 4
| -37.85% | -111.67K |
$16.50 | -$1,842,505.50 | 183.33K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 4
| +7.27% | 20K |
$12.39 | $247,783.46 | 295K |
Aug 29
| |||
Form 4
| +10.00% | 25K |
$9.79 | $244,871.88 | 275K |
May 13 - May 14
| |||
Form 4
|
∞
| 250K |
—
|
—
| 250K |
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||